Additionally, the estimated HR should be higher if the glycosylated hemoglobin A1c and glycemic control are the confounding factors in this study because individuals who used GLP-1 RAs (as second-line treatment for diabetes in Sweden) in our study could have poor glucose control compared to those individuals who did not use GLP-1 RAs. This evidence concerns the gene GLP1R and diabetes mellitus.